15th INTERNATIONAL CONGRESS OF PARKINSON'S

Abstracts
by topic
108
Abstracts by Topic
634 Results of a multicentre open study on the treatment of
heterogeneous subtypes of cervical dystonia with 500 units
abobotulinumtoxinA with a focus on quality of life
H. Hefter, R. Benecke, F. Erbguth, W. Jost, G. Reichel, J. Wissel
(Duesseldorf, Germany)
635 Impaired saccadic adaptation in DYT11 dystonia
C. Hubsch, M. Vidailhet, S. Rivaud-Péchoux, P. Pouget, V. Brochard,
B. Degos, D. Pelisson, B. Gaymard, R. Roze (Paris, France)
636 Cervical dystonia patient registry for observation of
onabotulinumtoxinA efficacy (CD PROBE): Study design of a
prospective observational registry
J. Jankovic, M. Stacy, P.D. Charles, C.H. Adler, C. Comella, M. Brin,
S. Papapetropoulos, CD PROBE Study Group (Houston, Texas, USA)
637 Factors associated with efficacy and side effects of botulinum toxin A
injections in focal hand dystonia
A. Kaelin-Lang, M. Andrea, W.M.M. Schuepbach (Bern, Switzerland)
638 Improvement of childhood dystonia following pallidal deep brain
stimulation (DBS) in relation to disease duration and severity at the
time of surgery
M. Kaminska, K. Tustin, H. Gimeno, L. Baker, S. Perides,
D.E. Lumsden, R. Selway, K. Ashkan, J.-P. Lin (London, United
Kingdom)
639 Long-term effectiveness of botulinum toxin injections treating
psychogenic movement disorders
P. Kassavetis, M.J. Edwards, I. Pareés, T.A. Saifee, K.P. Bhatia,
C. Cordivari (London, United Kingdom)
640 Pre-injection, multi-channel EMG mapping to optimize
onabotulinum toxin A efficacy in cervical dystonia
C.W. Kilbane, J.L. Ostrem, N.B. Galifianakis, J. Grace, L.C. Markun,
G.A. Glass (San Francisco, California, USA)
641 A CADASIL patient presenting with extrapyramidal symptoms
S.J. Kim, E.J. Chung (Busan, Korea)
642 First report of a patient with myoclonus-dystonia (DYT-11)
improved by bilateral pallidal stimulation in Japan
K. Kimura, F. Yokochi, R. Okiyama, A. Uruha, M. Taniguchi, Y. Aoki,
K. Ishii, S. Kumada, T. Kawasaki, A. Isoo (Tokyo, Japan)
643 Biperiden for segmental and generalized dystonia: An open-label
study
N. Kovacs, F. Nagy, Z. Aschermann, J. Jozsef, E. Pal (Pécs, Hungary)
644 DYT6 phenotipe in Serbian population
N. Kresojevic, M. Svetel, I. Novakovic, V. Dobricic, V.S. Kostic
(Belgrade, Serbia)
645 Botulinum-A neurotoxin in trigeminal neuralgia and blepharospasm:
7 years follow-up, a case report
R. López-Contreras, R. López-Castellanos (San Salvador, El Salvador)
646 The phenotypic and genotypic characters in a familial general
dystonia with DYT6 mutation
S.-C. Lai, T.-H. Yeh, W.-Y. Lin, C.-C. Chen, Y.-H. Weng, C.-S. Lu
(Taoyuan, Taiwan)
647 Expansion of the genotypic and phenotypic spectra of THAP1
mutations
M.S. LeDoux, J. Xiao, M. Rudzinska, R.W. Bastian, J.A. Van Gerpen,
Z.K. Wszolek (Memphis, Tennessee, USA)
648 Pool-based genome-wide association study of late-onset primary
dystonia
M.S. LeDoux, J. Xiao, R.W. Bastian, J.S. Perlmutter, B.A. Racette,
S.D. Tabbal, M. Karimi, R.C. Paniello, Z.K. Wszolek, R.J. Uitti,
J.A. Van Gerpen, D.K. Simon, D. Tarsy, P. Hedera, D.D. Truong,
K.P. Frei, A. Blitzer, Y. Zhao, R.F. Pfeiffer, M. Rudzinska (Memphis,
Tennessee, USA)
649 Alteration of ictal and interictal perfusion in paroxysmal kinesigenic
dyskinesia
K.-S. Lee, Y.-D. Kim, J.-S. Kim, I.-U. Song, Y.-A. Chung (Seoul,
Republic of Korea)
650 Paroxysmal non-kinesiogenic dyskinesia, dystonia and gait disorder
secondary to mild GLUT1 deficiency
S.G. Finnegan, D.G. Lichter (Buffalo, New York, USA)
651 Successful use of trihexyphenidyl in a patient with generalised
dystonia affecting oro-lingual and manual dexterity
L. Baker, H. Gimeno, K. Tustin, J.P. Lin (London, United Kingdom)
652 Study of dopamine transporter binding in a Taiwanese Segawa’s
disease family presenting with clinically intrafamilial variability
J.-J. Lin, K.-C. Yueh, C.-S. Lu (Chushang Jenn, Nantou County,
Taiwan)
653 Suicidality with GPi stimulation
C. Linder, M. Aigner, K. Novak, W. Pirker, J. Lehrner, E. Auff, B. Voller
(Vienna, Austria)
654 Does dystonia severity account for carer perceptions of quality of life
in children?
D.E. Lumsden, L. Baker, S. Perides, H. Gimeno, K. Tustin,
M. Kaminska, R. Selway, J.-P. Lin (London, United Kingdom)
655 Use of clonidine in the treatment of life threatening paediatric
dystonia
D.E. Lumsden, D. Grigoratos, S. Arenas, S. Perides, A. Durwood,
M. Kaminska, J.-P. Lin (London, United Kingdom)
656 Pilot study of topical acetyl hexapeptide-8 (AH8) in treatment of
blepharospasm
C. Lungu, E. Considine, S. Zahir, M. Hallett (Bethesda, Maryland,
USA)
657 The natural history of spread in primary adult-onset dystonia
A. Macerollo, G. Abbruzzese, A. Berardelli, P. Girlanda, M. Tinazzi,
D. Martino, G. Defazio (Bari, Italy)
658 Central and extrapontine myelinolysis with severe dystonia and
progressive atrophy on MRI
K.M. Mackenzie, K.L. Poston, N. Fischbein (Stanford, California, USA)
659 Early response to pallidal stimulation DBS in children cerebral palsy
vs DYT-1 dystonia
W.A. Marks, J. Honeycutt, F. Acosta, Jr., L. Bailey, M.A. Reed (Fort
Worth, Texas, USA)
660 Cortical gray matter changes in primary blepharospasm: A voxelbased
morphometry study
D. Martino, A. Di Giorgio, E. D’Ambrosio, T. Popolizio, A. Macerollo,
A. Bertolino, G. Defazio (Bari, Italy)
661 Cerebellar theta burst stimulation in primary dystonia
P. Porcacchia, F.J. Palomar, F. Carrillo, M.T. Cáceres-Redondo,
V. Conde, G. Koch, P. Mir (Sevilla, Spain)